TFRC Protein

TFRC Protein

Overview

TFRC (Transferrin Receptor 1) is a cell surface receptor that mediates cellular iron uptake through transferrin endocytosis. It plays critical roles in iron homeostasis, cellular metabolism, and has been implicated in various neurodegenerative diseases through its involvement in iron dysregulation and cellular stress responses.[@transferrin2015][@brain2011]

Introduction

Transferrin Receptor 1 (TFRC or TfR1) is a type II transmembrane glycoprotein that facilitates the uptake of transferrin-bound iron into cells. As a key regulator of iron homeostasis, TFRC is essential for normal cellular function and viability. In the brain, TFRC is expressed on [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), and endothelial cells of the [blood-brain barrier](/entities/blood-brain-barrier), where it regulates iron entry into the central nervous system.[@iron2004]

Iron dysregulation is a hallmark of several neurodegenerative diseases, making TFRC an important therapeutic target. The receptor's role in cellular iron uptake, signal transduction, and protein metabolism provides multiple avenues for intervention in disease processes.

TFRC Protein

Overview

TFRC (Transferrin Receptor 1) is a cell surface receptor that mediates cellular iron uptake through transferrin endocytosis. It plays critical roles in iron homeostasis, cellular metabolism, and has been implicated in various neurodegenerative diseases through its involvement in iron dysregulation and cellular stress responses.[@transferrin2015][@brain2011]

Introduction

Transferrin Receptor 1 (TFRC or TfR1) is a type II transmembrane glycoprotein that facilitates the uptake of transferrin-bound iron into cells. As a key regulator of iron homeostasis, TFRC is essential for normal cellular function and viability. In the brain, TFRC is expressed on [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), and endothelial cells of the [blood-brain barrier](/entities/blood-brain-barrier), where it regulates iron entry into the central nervous system.[@iron2004]

Iron dysregulation is a hallmark of several neurodegenerative diseases, making TFRC an important therapeutic target. The receptor's role in cellular iron uptake, signal transduction, and protein metabolism provides multiple avenues for intervention in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Transferrin Receptor 1</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Transferrin Receptor 1</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/tfrc">TFRC</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P02786">P02786</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1CX8, 1XHA, 2HC8</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>190 kDa (homodimer)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Plasma membrane, endosomes</td></tr>
<tr><td><strong>Protein Family</strong></td><td>MHC class I family</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, highest in proliferating cells</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-959a4677" style="color:#ce93d8" title="Score: 0.53">Blood-Brain Barrier SPM Shuttle System...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">216 edges</a></td>
</tr>
</table>
</div>

Structure

Transferrin Receptor 1 is a homodimeric protein, with each monomer consisting of:[@structure2004]

• Extracellular domain: The large ectodomain (~660 amino acids) contains the transferrin binding site and is heavily glycosylated
• Transmembrane domain: Single pass (~28 amino acids) anchoring the protein in the plasma membrane
• Cytoplasmic domain: Short intracellular tail (~61 amino acids) containing sorting signals for endocytosis and recycling

Structural Features

• Monomer molecular weight: ~95 kDa
• Dimerization: Occurs through disulfide bonds in the transmembrane domain
• Iron binding: Each transferrin molecule can bind 2 Fe³⁺ ions; TFRC binds diferric transferrin with high affinity
• pH sensitivity: Binding is pH-dependent, releasing iron in acidic endosomes

Normal Function

TFRC is a cell surface receptor that mediates cellular iron uptake through transferrin endocytosis.[@molecular2002]

Iron Uptake Pathway

Cellular Functions

• Iron homeostasis: Primary pathway for cellular iron acquisition
• Cell proliferation: Iron is required for DNA synthesis; TFRC expression correlates with proliferative capacity
• Erythropoiesis: Essential for red blood cell precursor iron uptake
• Brain iron import: Mediates iron entry across the blood-brain barrier via transferrin receptor-mediated endocytosis[@transferrin1999]
• Cellular metabolism: Supports mitochondrial function and DNA synthesis
• Immune function: Regulates immune cell proliferation and activation

Role in Neurodegeneration

Iron dysregulation is a key pathological feature of multiple neurodegenerative disorders. TFRC plays a complex role in these processes through several mechanisms:[@tfrc2017][@iron2015]

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), TFRC is involved in:[@iron2012]

• Iron accumulation: Elevated iron in AD brain correlates with disease progression
• Amyloid interaction: TFRC may interact with [amyloid precursor protein](/entities/app-protein) (APP) processing
• Oxidative stress: Iron-induced [ROS](/entities/reactive-oxygen-species) generation through Fenton chemistry
• Blood-brain barrier: Altered TFRC expression affects brain iron homeostasis
• [Tau](/proteins/tau) pathology: Iron can promote tau hyperphosphorylation and aggregation

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), TFRC contributes to:[@iron2002]

• Nigral iron accumulation: Elevated TFRC expression in substantia nigra
• Dopaminergic vulnerability: High iron uptake may increase oxidative stress
• Neuromelanin binding: Iron-loaded neuromelanin can trigger neurodegeneration
• Mitochondrial dysfunction: Iron overload impairs mitochondrial function
• [Alpha-synuclein](/proteins/alpha-synuclein) interaction: Iron can accelerate α-synuclein aggregation

Other Neurodegenerative Disorders

• Amyotrophic Lateral Sclerosis (ALS): Altered iron metabolism and TFRC expression in motor neurons[@iron2015a]
• Huntington's Disease: Iron dysregulation contributes to striatal degeneration
• Multiple System Atrophy: Iron accumulation in affected brain regions
• Friedreich's Ataxia: Primary iron-sulfur cluster deficiency affecting TFRC function

Iron Homeostasis in the Brain

The blood-brain barrier expresses TFRC on endothelial cells, regulating iron entry into the CNS:[@bloodbrain2015]

• Transferrin-bound iron crosses via receptor-mediated endocytosis
• Brain iron levels increase with age
• Dysregulation leads to pathological iron accumulation
• [Ferroptosis](/entities/ferroptosis) (iron-dependent cell death) is implicated in neurodegeneration

Therapeutic Implications

TFRC represents a therapeutic target for modulating brain iron homeostasis:[@targeting2020]

Iron Chelation Therapy

• Deferoxamine: Classic iron chelator; limited brain penetration
• Deferasirox: Oral iron chelator with better CNS access
• Clioquinol: Metal-protein-attenuating compound; shown to reduce brain iron in clinical trials

Receptor-Targeted Approaches

• TFRC agonists: Enhance iron export from cells
• TFRC antagonists: Reduce cellular iron uptake (may be beneficial in iron overload)
• Antibody therapy: Anti-TFRC antibodies to modulate receptor function

Small Molecule Modulators

• Iron-specific chelators: Designed to target brain iron
• Neuroprotective compounds: Antioxidants that mitigate iron-induced damage
• Ferroptosis inhibitors: Liproxstatin-1, ferrostatin-1 under investigation

Biomarker Potential

Soluble TFRC (sTfR) in cerebrospinal fluid and blood has been studied as a biomarker:[@soluble2013]

• Reflects cellular iron demand and erythropoietic activity
• Altered levels in neurodegenerative diseases
• Potential for disease diagnosis and progression monitoring

Key Publications

See Also

• [TFRC Gene](/genes/tfrc) — Gene page for transferrin receptor
• [Iron Metabolism](/mechanisms/iron-metabolism) — Overview of brain iron homeostasis
• [Oxidative Stress](/mechanisms/oxidative-stress) — ROS in neurodegeneration
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) — Mitochondrial iron handling
• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
• [Parkinson's Disease](/diseases/parkinsons-disease) — PD overview
• [Ferroptosis](/mechanisms/ferroptosis) — Iron-dependent cell death

External Links

• [UniProt - TFRC](https://www.uniprot.org/uniprot/P02786)
• [NCBI Gene - TFRC](https://www.ncbi.nlm.nih.gov/gene/7037)
• [PDB - TFRC Structure](https://www.rcsb.org/structure/1CX8)
• [Human Protein Atlas - TFRC](https://www.proteinatlas.org/ENSG00000119711-TFRC)

Background

The study of Tfrc Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Blood-Brain Barrier SPM Shuttle System](/hypothesis/h-959a4677) — <span style="color:#ffd54f;font-weight:600">0.53</span> · Target: TFRC